OLIGONUKLEOTIDE ZUR REDUKTION DER PD-L1-EXPRESSION

European patent · EP3430141 · In force

Register entry

Publication number
EP3430141
Application number
EP17710874
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Mar 14, 2017
Published
Jan 23, 2019
Granted
Dec 30, 2020
Protection ends at the latest
Mar 13, 2037
Next annual fee due
Mar 31, 2027
IPC classes
C12N 15/113 (2010.01)
A61K 31/712 (2006.01)
A61K 31/7125 (2006.01)
A61K 47/50 (2017.01)
C07H 21/00 (2006.01)
A61P 37/04 (2006.01)
A61P 33/02 (2006.01)
A61P 31/00 (2006.01)
Priority
EP 16160149 14.03.2016
PCT application
PCT/EP2017/055925 14.03.2017
PCT publication
WO2017/157899 21.09.2017
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Apr 1, 2026

    Change

    Published in Swissreg on 01.04.2026

  2. Apr 1, 2025

    Change

    Published in Swissreg on 01.04.2025

  3. Apr 1, 2024

    Change

    Published in Swissreg on 01.04.2024

  4. Apr 1, 2023

    Change

    Published in Swissreg on 01.04.2023

  5. Nov 10, 2021

    Change

    Published in Swissreg on 10.11.2021

  6. Dec 30, 2020

    Granted

    Published in Swissreg on 30.12.2020

Parties

Holder

F. Hoffmann-La Roche AG

Grenzacherstrasse 124, 4070 Basel

Inventor

JACKEROTT, Malene

2970 Horsholm, DK

OTTOSEN, Søren

2970 Horsholm, DK

JAVANBAKHT, Hassan

4070 Basel

PEDERSEN, Lykke

2970 Horsholm, DK

LUANGSAY, Souphalone

4070 Basel

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.